2-Substitutedphenathiazine was prepared according to the reported method. Ethylsubstitutedphenothiazinoacetates(1a-1b) were prepared by the reaction of ethylchloroacetate in the presence of anhydrous K 2 CO 3. 2-amino-5-N 10 substitutedphenothiazinoacetyl)-semicarbazdes/ thiosemicarbazides (2a-2d) were synthesized by refluxing compound (1a-1b) with thiosemicarbazide/semicarbazide. Compounds (2a-2d) were then underwent mannich reaction to yield compounds 3a-3d. All the newly synthesized compounds (i.e. 2a-2d and 3a-3d) were evaluated for their anticonvulsant activity. Almost all the compounds have shown promising anticonvulsant activity. Compound 3d was the most potent compound of this series. The most potent compound was evaluated for its anticonvulsant activity and acute toxicity.
INTRODUCTION
Research in the field of barbituric acid derivatives has yielded a number of clinically useful anticonvulsant drugs. 10H-Phenothiazine nucleus has gained prominance due to its diverse activities like-anticonvulsant, [1] [2] [3] [4] [5] [6] antinflammatory 7 and cardiovascular 8 . The introduction of various heterocyclic / aliphatic moieties at 10-position of phenothiazine led to the discovery of promethazine [10-(2-methylaminopropyl) phenothiazine hydrochloride]. Chlorpromazine[2-chloro-10-3-(3-dimethylaminopropyl)phenothiazinehydrochloricle], which posses potent antihistamic and CNS
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www.orientjchem.org depressant activities respectively. Researchers has revealed that various 5-substituted barbituric acid derivatives possess potent anticonvulsant activity [9] [10] [11] [12] [13] [14] [15] [16] . In view of these observations, it was thought worthwhile to synthesize a new series of 5-substituted barbituric acid derivatives bearing phenothiazinyl moiety. All the newly synthesized compounds were evaluated for their anticonvulsant activity and acute toxicity studies. 2 ), which confirms the structure of compound 2c. Compounds (2a-2d) were then underwent mannich reaction to yield compounds 3a-3d. The formation of compound 3c is supported by the disappearance of a multiplet at d7.75 due to 4 protons of (NHNHCSNH 2 ) and appearance of a multiplied at 8.30 due to 3-protons of (NHNHCSNH), a single singlet at d 9.25 due to 1-proton of (NHCO), a singlet at d 2.95 due to the 1-proton of CH of barbituric acid and a doublet at 4.45 due to 2-protons of (NHCH 2 ) in the 1 H NMR spectrum. Its structure is further confirmed by the presence of bands at 1720, 1710, 1680 due to (C=O of barbituric acid, amidic CO).
Ethylsubstitutedphenothiazinoacetates

Pharmacological activities Anticonvulsant activity Maximum electroshock seizure (MES) test
This test was performed according to the method of Tomanet. al 17 The group of ten rats was treated with test drugs (50 mg/kg i.p.) / phentoin sodium (30 mg/kg i.p.) after 1h they were subjected to the shock of 150 mA by convulsiometer through ear electrodes for 0.2s and the presence or absence of extensor response was noted. Animals in which extensor response was abolished were taken as protected rats.
Pentylenetetrazole (PTZ) induced seizures Test
This test was performed by following the method of Fischer 18 . The rats were injected with pentylenetetrazol in dose of 70 mg /kg subcutaneously in scruff of neck. After 2-4 min. of PTZ injection animals developed sequence of excitement, myclonic jerks, clonic seizures, one or more maximum tonic seizures. Animals exhibiting these seizures patterns were selected.Standard drug used in this model was sodium valproate (80 mg/kg i.p.) and was injected 60 min prior to PTZ challenge. All the newly synthesized compounds were studied for their anticonvulsant activity at a dose of 50 mg /kg i.p. in maximal electroshock and pentylenetetrazole induced seizures respectively. All the mewly synthesized compounds have shown anticonvulsant activity in both the models (ranging from 30 to 90% and 20 to 90% in MES and PTZ models, respectively). The anticonvulsant activity of all the compounds are reported in Table 2 . Compound 3d was found to possess potent anticonvulsant activity it was studied three graded doses (17. 5, 25, and 50 mg/kg i.p.).
Acute toxicity study
ALD 50 values of some promising compounds were determined by observing 50% mortality after 24 hr 19 . ALD 50 value of most active compound i. e. 3d was > 2000 mg/kg p.o. (maximum dose tested).
EXPERIMENTAL
Melting points were taken in open capillary tubes and are uncorrected. Analytical data of C, H, N, were within ±0.04% of the theoretical value. IR spectra (KBr) are recorded on BackmannAcculab -10-spectrophotometer. 1 H NMR spectra were recorded by Bruker WM 400 FT instrument using CDCl 3 as solvent and tetramethylsilance (TMS) as internal reference standard. All chemical shift (d) are in ppm. The purities of the compounds were checked by thin layer chromatography (TLC) on silicagel -G plates of 0.5 mm thickness. The elemental analysis of the compounds were performed on Heracus Carlo Erba 1108 analyser.
Preparation of ethylsubstitutedphenothiazino acetates (1a-1b)
A mixture of substitutedphenothiazine/ phenothiazine (0.01 mole), ethylchloroacetate(0.01 mole) and anhydrous K 2 CO 3 (8.0 gm) in acetone (90 ml) were refluxed for 24 hours. After refluxing, the excess of solvent was distilled off. The reaction mixture was cooled, filtered and washed with water and recrystallized from appropriate solvents ( Table 1) .
Preparation of 2-amino-5-(N 10 -substituted phenothiazinoacetyl) semicarbazides/ thiosemi carbazides (2a-2d)
Compounds (1a-1b) (0.075 mole) and thiosemicarbazide / semicarbazide (0.075 mole) 
